Logo image of WEST

WESTROCK COFFEE CO (WEST) Stock Fundamental Analysis

NASDAQ:WEST - Nasdaq - US96145W1036 - Common Stock - Currency: USD

7.1  +0.13 (+1.87%)

After market: 7.1 0 (0%)

Fundamental Rating

1

Taking everything into account, WEST scores 1 out of 10 in our fundamental rating. WEST was compared to 91 industry peers in the Food Products industry. WEST has a bad profitability rating. Also its financial health evaluation is rather negative. WEST is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

In the past year WEST has reported negative net income.
WEST had a negative operating cash flow in the past year.
In the past 5 years WEST reported 4 times negative net income.
In the past 5 years WEST always reported negative operating cash flow.
WEST Yearly Net Income VS EBIT VS OCF VS FCFWEST Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -50M -100M -150M -200M

1.2 Ratios

WEST's Return On Assets of -4.07% is on the low side compared to the rest of the industry. WEST is outperformed by 68.13% of its industry peers.
With a Return On Equity value of -10.18%, WEST is not doing good in the industry: 69.23% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROIC N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
WEST Yearly ROA, ROE, ROICWEST Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -50 -100

1.3 Margins

WEST's Gross Margin of 16.27% is in line compared to the rest of the industry. WEST outperforms 42.86% of its industry peers.
The Profit Margin and Operating Margin are not available for WEST so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 16.27%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
WEST Yearly Profit, Operating, Gross MarginsWEST Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 5 -5 10 15

More info and screens

1

2. Health

2.1 Basic Checks

WEST does not have a ROIC to compare to the WACC, probably because it is not profitable.
WEST has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
WEST Yearly Shares OutstandingWEST Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 20M 40M 60M 80M
WEST Yearly Total Debt VS Total AssetsWEST Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

WEST has an Altman-Z score of 1.35. This is a bad value and indicates that WEST is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.35, WEST is doing worse than 63.74% of the companies in the same industry.
WEST has a Debt/Equity ratio of 0.89. This is a neutral value indicating WEST is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.89, WEST is not doing good in the industry: 68.13% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Altman-Z 1.35
ROIC/WACCN/A
WACC8.77%
WEST Yearly LT Debt VS Equity VS FCFWEST Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 200M -200M

2.3 Liquidity

A Current Ratio of 1.31 indicates that WEST should not have too much problems paying its short term obligations.
WEST has a worse Current ratio (1.31) than 61.54% of its industry peers.
WEST has a Quick Ratio of 1.31. This is a bad value and indicates that WEST is not financially healthy enough and could expect problems in meeting its short term obligations.
WEST has a worse Quick ratio (0.68) than 65.93% of its industry peers.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 0.68
WEST Yearly Current Assets VS Current LiabilitesWEST Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 100M 200M 300M

More info and screens

3

3. Growth

3.1 Past

The earnings per share for WEST have decreased strongly by -30.00% in the last year.
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.41%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.06%

3.2 Future

The Earnings Per Share is expected to grow by 33.91% on average over the next years. This is a very strong growth
Based on estimates for the next years, WEST will show a quite strong growth in Revenue. The Revenue will grow by 17.77% on average per year.
EPS Next Y42.12%
EPS Next 2Y44.63%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue Next Year21.13%
Revenue Next 2Y17.9%
Revenue Next 3Y17.77%
Revenue Next 5YN/A

3.3 Evolution

WEST Yearly Revenue VS EstimatesWEST Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2022 2023 2024 2025 2026 2027 500M 1B
WEST Yearly EPS VS EstimatesWEST Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4 -0.6 -0.8

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for WEST. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 87.01, WEST can be considered very expensive at the moment.
WEST's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of WEST to the average of the S&P500 Index (37.64), we can say WEST is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 87.01
WEST Price Earnings VS Forward Price EarningsWEST Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, WEST is valued a bit more expensive than 63.74% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 38.13
WEST Per share dataWEST EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6 8 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates WEST does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as WEST's earnings are expected to grow with 33.91% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.63%
EPS Next 3Y33.91%

More info and screens

0

5. Dividend

5.1 Amount

WEST does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

WESTROCK COFFEE CO

NASDAQ:WEST (7/25/2025, 8:00:01 PM)

After market: 7.1 0 (0%)

7.1

+0.13 (+1.87%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)05-08 2025-05-08/amc
Earnings (Next)08-07 2025-08-07/amc
Inst Owners32.76%
Inst Owner Change0.56%
Ins Owners5.97%
Ins Owner Change1.35%
Market Cap671.94M
Analysts83.64
Price Target10.81 (52.25%)
Short Float %18.35%
Short Ratio22.03
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-3070.57%
Min EPS beat(2)-6671.48%
Max EPS beat(2)530.34%
EPS beat(4)1
Avg EPS beat(4)-2146.95%
Min EPS beat(4)-6671.48%
Max EPS beat(4)530.34%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-7.65%
Min Revenue beat(2)-8.54%
Max Revenue beat(2)-6.76%
Revenue beat(4)0
Avg Revenue beat(4)-7.83%
Min Revenue beat(4)-8.54%
Max Revenue beat(4)-6.76%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-1.85%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 87.01
P/S 0.63
P/FCF N/A
P/OCF N/A
P/B 1.73
P/tB 4.51
EV/EBITDA 38.13
EPS(TTM)-0.91
EYN/A
EPS(NY)0.08
Fwd EY1.15%
FCF(TTM)-2.42
FCFYN/A
OCF(TTM)-0.68
OCFYN/A
SpS11.31
BVpS4.1
TBVpS1.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -4.07%
ROE -10.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 16.27%
FCFM N/A
ROA(3y)-3.91%
ROA(5y)N/A
ROE(3y)-11.28%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover1.1
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF N/A
Debt/EBITDA 15.65
Cap/Depr 619.86%
Cap/Sales 15.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.31
Quick Ratio 0.68
Altman-Z 1.35
F-Score2
WACC8.77%
ROIC/WACCN/A
Cap/Depr(3y)327.2%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-30%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-7.41%
EPS Next Y42.12%
EPS Next 2Y44.63%
EPS Next 3Y33.91%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%11.06%
Revenue Next Year21.13%
Revenue Next 2Y17.9%
Revenue Next 3Y17.77%
Revenue Next 5YN/A
EBIT growth 1Y-133.46%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1139.04%
EBIT Next 3Y219.97%
EBIT Next 5Y148.98%
FCF growth 1Y-90.62%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-13.13%
OCF growth 3YN/A
OCF growth 5YN/A